FMR1 and Intellectual disability: Meanwhile, current next-generation sequencing platforms (panels of intellectual disability genes or clinical exome sequencing) could identify patients with point mutations and deletions in FMR1, which may have been missed by current techniques testing only the CGG repeat size, thus further refining the estimates of Fragile X prevalence.